Drug Type Microbiota |
Synonyms VAP product (Pulmobiotics) |
Target |
Action modulators |
Mechanism PcrV modulators(Pseudomonas aeruginosa PvrV protein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pneumonia, Ventilator-Associated | Preclinical | Spain | 22 Sep 2024 |